This high-affinity fusion protein showed superior blockade of both APRIL/BCMA signaling and BAFF-TACI/BAFF-R signaling in MM and DLBCL models, while demonstrating little toxicity and an on-target mechanism of action in nonhuman primate studies. This evidence concerns the gene TNFRSF13C and Miyoshi myopathy.